Data / Form D filings / AVALON PHARMACEUTICALS INC
AVALON PHARMACEUTICALS INC: Form D filing
AVALON PHARMACEUTICALS INC, a pharmaceuticals company in Germantown, MD, filed a Form D with the SEC in 2008. The latest, on November 7, 2008, reports $237,338 sold of a $237,338 offering to 1 investor.
Find out what AVALON PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20358 SENECA MEADOWS PARKWAY, Germantown, MD, 20876
- Phone
- (301) 556-9900
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- De
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1162192
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2008 | New notice | $237,338 | $237,338 | $0 | 1 | Oct 27, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen K. Horrigan | Executive Officer | |
| J. Michael Hamilton | Executive Officer | |
| David S. Kabakoff | Director | |
| Bradley G. Lorimier | Director | |
| C. Eric Winzer | Executive Officer | |
| Kenneth C. Carter | Executive Officer, Director | |
| William H. Washecka | Director | |
| Philip Frost | Director | |
| Michael R. Kurman | Director |
Every Form D from the week of Nov 3, 2008 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AVALON PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.